Experiments optimize astaxanthin yield in engineered E. coli, suggesting effective methods for enhancing production.
Astaxanthin biosynthesis in engineered Escherichia coli was intensified by coupling fermentation optimization with modular enzyme self-assembly. Single-factor screens followed by an L9 (3^4) orthogonal design quantified how cultivation time, temperature, agitation, and IPTG concentration shape astaxanthin accumulation. A back-propagation neural network (BPNN) trained on these data sets accurately predicted titres (R² = 0.98). Range analysis of the orthogonal array identified an optimal discrete operating point (36 h, 18°C, 150 rpm, 4 mM IPTG), which was further supported by the BPNN landscape and validated experimentally to yield 597.06 ± 21.32 µg g⁻¹ dry cell weight (DCW). We then repurposed orthogonal docking-domain pairs from type I trans-AT polyketide synthases to co-localize terminal enzymes in the carotenoid pathway, increasing astaxanthin production to 1.3 mg g⁻¹ DCW in strain sE. HC073 (2.2-fold over the fermentation-optimized control). Together, these results show that data-driven process selection and selective spatial organization provide complementary levers for building higher-yield carotenoid cell factories.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: